Skip to content
Open access · OA via Europe PMC

Genetic Risk Architecture of Late-Onset Alzheimer's Disease: Mapping Single-Nucleotide Polymorphisms to Disease-Defining Molecular Pathways.

Matei C, Palade NA, Dobri-Nicoara AM, Dumitriu DO, Mutu C, Popescu ASC, Pintea AL, Atasie D.

Life (Basel, Switzerland) · 2026

Abstract

Late-onset Alzheimer's disease (LOAD) is increasingly recognized as a complex, multifactorial disorder driven by the convergence of genetic susceptibility and interconnected molecular pathways, rather than a single linear pathogenic cascade. In this review, we integrate evidence from genome-wide association studies, sequencing analyses, and experimental research to map disease-associated single-nucleotide polymorphisms (SNPs) onto key biological processes underlying LOAD pathogenesis. Converging data consistently implicate a limited number of core domains, including amyloid-β metabolism, tau pathology, neuroinflammation, lipid homeostasis, endosomal-lysosomal trafficking, mitochondrial dysfunction(definition), and synaptic impairment. Importantly, genetic risk variants are not randomly distributed, but cluster within these pathways, exerting coordinated effects across multiple biological systems and supporting a network-based organization of disease. We further examine how these pathways interact at a systems level, highlighting key interfaces such as the amyloid-tau, lipid-immune, inflammation-proteostasis(definition), and mitochondria-synaptic dysfunction axes. These interconnected processes form self-reinforcing feedback loops that amplify neurodegeneration and contribute to disease progression. From a translational perspective, this integrated framework provides a mechanistic basis for the limited efficacy of single-target therapies and supports the development of multi-target and pathway-oriented strategies, as well as precision medicine approaches based on genetic and biomarker integration. Collectively, this review supports a unified model of LOAD as a polygenic network disorder and underscores the importance of pathway convergence in understanding disease heterogeneity and guiding future therapeutic development.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
Europe PMC
DOI
10.3390/life16101749
Canonical
link ↗
Fetched
2026-10-31 MST

Cite this

APA
C, M., NA, P., AM, D., DO, D., C, M., ASC, P., AL, P., &amp; D., A. (2026). Genetic Risk Architecture of Late-Onset Alzheimer's Disease: Mapping Single-Nucleotide Polymorphisms to Disease-Defining Molecular Pathways. <em>Life (Basel, Switzerland)</em>. https://doi.org/10.3390/life16101749
Vancouver
C M, NA P, AM D, DO D, C M, ASC P, et al. Genetic Risk Architecture of Late-Onset Alzheimer's Disease: Mapping Single-Nucleotide Polymorphisms to Disease-Defining Molecular Pathways. Life (Basel, Switzerland). 2026. doi:10.3390/life16101749.
BibTeX
@article{matei2026Geneti, title = {Genetic Risk Architecture of Late-Onset Alzheimer's Disease: Mapping Single-Nucleotide Polymorphisms to Disease-Defining Molecular Pathways.}, author = {Matei C and Palade NA and Dobri-Nicoara AM and Dumitriu DO and Mutu C and Popescu ASC and Pintea AL and Atasie D.}, journal = {Life (Basel, Switzerland)}, year = {2026}, doi = {10.3390/life16101749}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings